First Commonwealth Financial Corp Amgen Inc Transaction History

First Commonwealth Financial Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $7,613 - $8,472	-33 Reduced 3.09%	1,035 $252,000
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $16,664 - $18,435	-76 Reduced 6.64%	1,068 $258,000
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $795 - $910	-4 Reduced 0.35%	1,144 $257,000
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $3,050 - $3,392	13 Added 1.15%	1,148 $292,000
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $14,044 - $17,234	71 Added 6.67%	1,135 $268,000
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $193,903 - $257,168	1,064 New	1,064 $216,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $151B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of First Commonwealth Financial Corp , based on Form 13F filings with the SEC.

Stay updated on First Commonwealth Financial Corp with notifications on news.